Tefferi A - Search Results

1

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.

Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferarri ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Harrison CN, Radia D, Mesa RA. Scherber R, et al. Among authors: tefferi a. Blood. 2011 Jul 14;118(2):401-8. doi: 10.1182/blood-2011-01-328955. Epub 2011 May 2. Blood. 2011. PMID: 21536863 Free article.

2

Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications.

Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA Jr. Tefferi A, et al. Semin Thromb Hemost. 1997;23(4):379-83. doi: 10.1055/s-2007-996112. Semin Thromb Hemost. 1997. PMID: 9263355 Review.

3

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Yoon SY, Li CY, Mesa RA, Tefferi A. Yoon SY, et al. Among authors: tefferi a. Br J Haematol. 1999 Sep;106(3):682-8. doi: 10.1046/j.1365-2141.1999.01598.x. Br J Haematol. 1999. PMID: 10468856 Free article.

4

Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN. Tefferi A, et al. Blood. 2000 Apr 1;95(7):2226-33. Blood. 2000. PMID: 10733489 Free article.

5

Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.

Mesa RA, Elliott MA, Tefferi A. Mesa RA, et al. Among authors: tefferi a. Blood Rev. 2000 Sep;14(3):121-9. doi: 10.1054/blre.2000.0132. Blood Rev. 2000. PMID: 10986148 Review.

6

Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.

Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Mesa RA, et al. Among authors: tefferi a. Blood. 2000 Nov 15;96(10):3374-80. Blood. 2000. PMID: 11071630 Free article.

7

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.

Tefferi A, Elliot MA, Yoon SY, Li CY, Mesa RA, Call TG, Dispenzieri A. Tefferi A, et al. Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896. Blood. 2001. PMID: 11263440 Free article. Clinical Trial. No abstract available.

8

Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.

Mesa RA, Li CY, Schroeder G, Tefferi A. Mesa RA, et al. Among authors: tefferi a. Blood. 2001 Jun 1;97(11):3665-7. doi: 10.1182/blood.v97.11.3665. Blood. 2001. PMID: 11369668 Free article.

9

Palliative splenectomy in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A. Mesa RA, et al. Among authors: tefferi a. Leuk Lymphoma. 2001 Sep-Oct;42(5):901-11. doi: 10.3109/10428190109097709. Leuk Lymphoma. 2001. PMID: 11697645 Review.

10

A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.

Rajkumar SV, Mesa RA, Tefferi A. Rajkumar SV, et al. Among authors: tefferi a. J Hematother Stem Cell Res. 2002 Feb;11(1):33-47. doi: 10.1089/152581602753448522. J Hematother Stem Cell Res. 2002. PMID: 11847002 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,188 results

Search Page

Filters